Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)
China flag China · Delayed Price · Currency is CNY
5.98
+0.09 (1.53%)
Aug 11, 2026, 3:04 PM CST

SHE:300639 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
661.41669.64815.531,1045,5972,673
Revenue Growth
-13.71%-17.89%-26.16%-80.27%109.39%97.34%
Gross Profit
282.13292.28375.18662.353,7901,808
Operating Income
-171.83-188.4-810.23-5.622,4241,046
Net Income
-106.43-130.94-654.88140.471,726852.16
Earnings Per Share
-0.17-0.21-1.02-2.621.29
EPS Growth
----102.58%118.80%

Revenue by Segment

Fiscal YearFY 2025
Period EndingDec '25
in Vitro Diagnostic Reagents, Supporting Instruments and Consumables
549.6
Medical Testing Services
267.26
Medical Services
27.49
Offset of Business Segment
-174.71
Total
669.64

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
950.871,039963.271,0721,4121,199
Total Debt
87.3189.5687.5156.65139.49185.15
Net Cash (Debt)
863.55949.15875.761,0151,2721,014
Net Cash Growth
55.35%8.38%-13.75%-20.20%25.48%-13.74%
Net Cash Per Share
1.381.521.36-1.931.54

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
319.64341.6178.78319.61,309631.34
Capital Expenditures
-94.65-92.39-148.33-385.32-734.37-641.07
Free Cash Flow
225249.21-69.55-65.72574.85-9.73
Free Cash Flow Growth
224.15%-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
42.66%43.65%46.01%59.97%67.72%67.62%
Operating Margin
-25.98%-28.13%-99.35%-0.51%43.30%39.13%
Pretax Margin
-19.38%-25.29%-102.14%3.33%38.02%39.55%
Profit Margin
-16.09%-19.55%-80.30%12.72%30.84%31.88%
FCF Margin
34.02%37.22%-8.53%-5.95%10.27%-0.36%

Dividends

Fiscal YearFY 2023FY 2022FY 2021
Period EndingDec '23 Jan '23 Jan '22
Dividend Per Share
0.0650.2330.155
Dividend Per Share Growth
-72.14%50.03%74.13%
Dividend Yield
0.70%2.15%1.24%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
---42.644.2610.09
Forward PE
-18.8924.2023.954.8812.96
P/FCF Ratio
16.6813.55--12.81-
PS Ratio
5.675.044.635.421.323.22